Karyopharm Therapeutics (KPTI) PT Raised to $11 at Wedbush
Tweet
Share
E-mailGet Alerts KPTI Hot Sheet
Price: $1.09 --0%
Rating Summary:
12 Buy, 4 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 11 | New: 14
Rating Summary:
12 Buy, 4 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 11 | New: 14
Join SI Premium – FREE
Wedbush analyst David Nierengarten raised the price target on Karyopharm Therapeutics (NASDAQ: KPTI) to $11.00 (from $6.00) while maintaining an Outperform rating following XPOVIO approval.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Boston Scientific (BSX) PT Raised to $83 at Stifel
- Compass Minerals International (CMP) PT Lowered to $15 at Deutsche Bank
- Citi Upgrades United Microelectronics Corp (2303:TT) (UMC) to Buy 'with limited downside'
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
